老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Osteopore
0.004
0.000
成交量:
- -
成交額:
- -
市值:
277.44萬
市盈率:
-0.27
高:
0.004
開:
0.004
低:
0.004
收:
0.004
52周最高:
0.029
52周最低:
0.003
股本:
6.94億
流通股本:
2.08億
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.015
每股收益(LYR):
-0.020
淨資產收益率:
-487.52%
總資產收益率:
-57.24%
市淨率:
-1.54
市盈率(LYR):
-0.20
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Osteopore攜手Zimmer Biomet,其顱頜面產品成功獲准進入沙特阿拉伯市場
美股速递
·
07/07
Osteopore Ltd 啓動單側唇裂患者鼻旁骨填充臨床研究
美股速递
·
06/02
Osteopore獲海南藥監局批准生產骨科定製醫療器械
投资观察
·
05/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/OSX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"OSX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","market":"AU","secType":"STK","nameCN":"Osteopore","latestPrice":0.004,"timestamp":1789711920000,"preClose":0.004,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"Osteopore","floatShares":207851789,"shares":693592914,"eps":-0.015,"marketStatus":"休市中","change":0,"latestTime":"09-18 16:12:00 AEST","open":0.004,"high":0.004,"low":0.004,"amount":0,"amplitude":0,"askPrice":0.004,"askSize":2383726,"bidPrice":0.003,"bidSize":19033364,"shortable":3,"etf":0,"ttmEps":-0.015,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789948800000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.004,"openAndCloseTimeList":[[1789689600000,1789711200000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSX.AU","preClose":0.004,"auctionPrice":0.004,"auctionVolume":800000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789624800913}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","floatShares":207851789,"roa":"-57.24%","roe":"-487.52%","lyrEps":-0.019761,"shares":693592914,"dividePrice":0,"high":0.004,"amplitude":0,"preClose":0.004,"low":0.004,"week52Low":0.003,"pbRate":"-1.54","psRate":"0.95","week52High":0.029,"institutionHeld":0,"latestPrice":0.004,"committee":0.7774,"eps":-0.015,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.015,"open":0.004,"prevYearClose":0.006,"prevWeekClose":0.004,"prevMonthClose":0.004,"prevQuarterClose":0.004,"fiveDayClose":0.004,"twentyDayClose":0.004,"sixtyDayClose":0.004,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"OSX.AU","defaultRemindTime":1708642800000,"type":"split","dateTimestamp":1708606800000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148865604","title":"Osteopore攜手Zimmer Biomet,其顱頜面產品成功獲准進入沙特阿拉伯市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1148865604","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148865604?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 06:35","pubTimestamp":1783377342,"startTime":"0","endTime":"0","summary":"Osteopore已成功为其颅颌面产品获得沙特阿拉伯市场的准入资格。此次市场进入将通过与国际医疗技术巨头Zimmer Biomet建立的合作伙伴关系进行分销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159500944","title":"Osteopore Ltd 啓動單側唇裂患者鼻旁骨填充臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1159500944","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159500944?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 07:10","pubTimestamp":1780355415,"startTime":"0","endTime":"0","summary":"Osteopore Ltd 宣布,已正式启动一项针对单侧唇裂患者的鼻旁骨填充临床研究。这项研究旨在评估公司专有骨组织工程支架在修复相关面部骨骼缺陷中的安全性与有效性,标志着其在颅颌面修复应用领域迈出了关键一步。该临床研究的推进,有望为这类患者群体提供新的、更优的再生医学治疗选择,同时也可能为公司的核心产品线开辟重要的临床应用市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121972246","title":"Osteopore獲海南藥監局批准生產骨科定製醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=1121972246","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121972246?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 09:31","pubTimestamp":1779759062,"startTime":"0","endTime":"0","summary":"5月26日(路透社)—— Osteopore有限公司宣布,其骨科定制医疗器械已获得海南省药品监督管理局的批准。这一进展标志着该公司在特定医疗设备领域的监管准入取得了关键突破,为其相关产品在中国市场的应用铺平了道路。\n该批准涉及为患者量身定制的骨科医疗装置,此类产品通常用于复杂的骨骼修复与重建手术。获得地方监管机构的许可是医疗器械公司商业化进程中的重要一步。\n更多关于该公司的信息,请参考其股票代码:OSX.AX。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OSX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}